OBJECTIVES: To evaluate the time to onset and the predictors of atrial fibrillation (AF) during long term follow up of patients with typical atrial flutter (AFL) treated with transisthmic ablation. DESIGN: Prospective multicentre study. METHODS AND RESULTS: 383 patients (75.4% men, mean (SD) age 61.7 (11.1) years) who underwent transisthmic ablation for typical AFL were investigated. In 239 patients (62.4%) AF was present before ablation. Ablation proved successful in 367 patients (95.8%). During a mean (SD) follow up of 20.5 (12.4) months, 41.5% of patients reported AF. The cumulative probability of postablation AF increased continuously as time passed: it was 22% at six months, 36% at one year, 50% at two years, 58% at three years, and 63% at four years. CONCLUSIONS: AF occurred in a large proportion of patients after transisthmic catheter ablation of typical AFL. The occurrence of AF was progressive during follow up. Preablation AF, age < 65 years, and left atrial size > 50 mm are associated with postablation AF occurrence.
OBJECTIVES: To evaluate the time to onset and the predictors of atrial fibrillation (AF) during long term follow up of patients with typical atrial flutter (AFL) treated with transisthmic ablation. DESIGN: Prospective multicentre study. METHODS AND RESULTS: 383 patients (75.4% men, mean (SD) age 61.7 (11.1) years) who underwent transisthmic ablation for typical AFL were investigated. In 239 patients (62.4%) AF was present before ablation. Ablation proved successful in 367 patients (95.8%). During a mean (SD) follow up of 20.5 (12.4) months, 41.5% of patients reported AF. The cumulative probability of postablation AF increased continuously as time passed: it was 22% at six months, 36% at one year, 50% at two years, 58% at three years, and 63% at four years. CONCLUSIONS:AF occurred in a large proportion of patients after transisthmic catheter ablation of typical AFL. The occurrence of AF was progressive during follow up. Preablation AF, age < 65 years, and left atrial size > 50 mm are associated with postablation AF occurrence.
Authors: B Fischer; M Haissaguerre; S Garrigues; F Poquet; L Gencel; J Clementy; F I Marcus Journal: J Am Coll Cardiol Date: 1995-05 Impact factor: 24.094
Authors: M H Hsieh; C T Tai; C F Tsai; W C Yu; W S Lin; J L Huang; Y A Ding; M S Chang; S A Chen Journal: Pacing Clin Electrophysiol Date: 2001-01 Impact factor: 1.976
Authors: C Pappone; S Rosanio; G Oreto; M Tocchi; F Gugliotta; G Vicedomini; A Salvati; C Dicandia; P Mazzone; V Santinelli; S Gulletta; S Chierchia Journal: Circulation Date: 2000-11-21 Impact factor: 29.690
Authors: Axel Meissner; Martin Christ; Petra Maagh; Rolf Borchard; Marc van Bracht; Ingo Wickenbrock; Hans-Joachim Trappe; Gunnar Plehn Journal: Clin Res Cardiol Date: 2007-08-31 Impact factor: 5.460
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: Circulation Date: 2014-03-28 Impact factor: 29.690
Authors: João Mesquita; Diogo Cavaco; António Miguel Ferreira; Francisco Moscoso Costa; Pedro Carmo; Francisco Morgado; Miguel Mendes; Pedro Adragão Journal: J Interv Card Electrophysiol Date: 2018-03-06 Impact factor: 1.900
Authors: Béatrice Brembilla-Perrot; Jean Marc Sellal; Arnaud Olivier; Vladimir Manenti; Thibault Villemin; Daniel Beurrier; Christian De Chillou; Zohra Lamiral; Nicolas Girerd Journal: PLoS One Date: 2015-05-22 Impact factor: 3.240
Authors: Javier García Seara; Francisco Gude; Pilar Cabanas; José L Martínez-Sande; Xesús Fernández López; Antonio Hernández Madrid; Concepción Moro; José R González Juanatey Journal: Health Qual Life Outcomes Date: 2012-08-06 Impact factor: 3.186
Authors: A S Thornton; P Janse; M Alings; M F Scholten; J M Mekel; M Miltenburg; E Jessurun; L Jordaens Journal: J Interv Card Electrophysiol Date: 2008-03-25 Impact factor: 1.900